| Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone (NCT00551811) | GlaxoSmithKline | 2007-10-08 |
| Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans (NCT00541866) | Sunesis Pharmaceuticals | 2007-10-06 |
| Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome (NCT00589316) | Fred Hutchinson Cancer Center | 2007-10-05 |
| Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy Subjects (NCT00538057) | GlaxoSmithKline | 2007-10-02 |
| A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g) (NCT00497497) | Genentech, Inc. | 2007-10-01 |
| Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors (NCT00688116) | Synta Pharmaceuticals Corp. | 2007-10-01 |
| Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE) (NCT00945789) | Tanta University | 2007-10-01 |
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy (NCT00540332) | Swedish Orphan Biovitrum | 2007-10-01 |
| An In-Hospital Family Member Cardiopulmonary Resuscitation (CPR) Education Program (NCT01260441) | University of Pennsylvania | 2007-10-01 |
| Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects (NCT00620230) | Novartis | 2007-10-01 |
| Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic Breathing (NCT00909259) | Respicardia, Inc. | 2007-10-01 |
| A Study to Examine the Absorption of GSK561679 in Healthy Male Volunteers (NCT00539136) | GlaxoSmithKline | 2007-10-01 |
| Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer (NCT00551421) | National Cancer Institute (NCI) | 2007-10-01 |
| Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00521261) | Barbara Ann Karmanos Cancer Institute | 2007-10-01 |
| Acute Hemodynamic Effects of Cocoa Polyphenols in Subjects With Hypertension and Optimal Blood Pressure (NCT00654862) | University of Cologne | 2007-10-01 |
| Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years (NCT00874549) | Sanofi Pasteur, a Sanofi Company | 2007-10-01 |
| A Comparative Safety and Activity Study With Ferroquine Associated With Artesunate Versus Amodiaquine Associated With Artesunate in African Adult Patients With Uncomplicated Malaria (NCT00563914) | Sanofi | 2007-10-01 |
| A Study of 18F-AV-45 in Healthy Volunteers (NCT01564706) | Avid Radiopharmaceuticals | 2007-10-01 |
| Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD) (NCT00783107) | University of Pittsburgh | 2007-10-01 |
| Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005 (NCT00544258) | Peplin | 2007-10-01 |
| A Pharmacokinetic, Tolerability, and Safety Study of ULTRAM ER in Children With Pain (NCT01586494) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-10-01 |
| Phase Ib Trial of MSP3 LSP in Children in Tanzania (NCT00469651) | African Malaria Network Trust | 2007-10-01 |
| Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese Subjects (NCT02141698) | Takeda | 2007-10-01 |
| Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril. (NCT00549510) | GlaxoSmithKline | 2007-10-01 |
| Tolerability of ALK Tree Tablet (NCT00535639) | ALK-Abelló A/S | 2007-10-01 |
| Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC (NCT00544453) | Molecular NeuroImaging | 2007-10-01 |
| Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants (NCT00673868) | Milton S. Hershey Medical Center | 2007-10-01 |
| Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers (NCT00548678) | Javelin Pharmaceuticals | 2007-10-01 |
| A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients (NCT00545246) | Sanofi | 2007-10-01 |
| Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer (NCT00547261) | Sanofi | 2007-10-01 |
| A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers (NCT00598819) | University of California, Irvine | 2007-10-01 |
| Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer (NCT01271166) | Novartis Pharmaceuticals | 2007-10-01 |
| Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen (NCT00556452) | University of Michigan Rogel Cancer Center | 2007-10-01 |
| A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men (NCT00549653) | GlaxoSmithKline | 2007-10-01 |
| Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED) (NCT01209741) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Study Evaluating the Safety of FXR-450 in Healthy Subjects (NCT00499629) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-10-01 |
| Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) Patients (NCT00736307) | Royan Institute | 2007-10-01 |
| Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer (NCT01445379) | National Cancer Institute (NCI) | 2007-10-01 |
| A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable (NCT00876109) | Genentech, Inc. | 2007-10-01 |
| Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease (NCT00774969) | S.L.A. Pharma AG | 2007-10-01 |
| Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy (NCT00715546) | Irmandade Santa Casa de Misericórdia de Porto Alegre | 2007-10-01 |
| Using Beta Blockers to Treat Mitral Regurgitation (NCT00700947) | Wake Forest University Health Sciences | 2007-10-01 |
| Study Evaluating the Tolerability of Bifeprunox in Healthy Subjects (NCT00581451) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-10-01 |
| Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients (NCT00569114) | Tragara Pharmaceuticals, Inc. | 2007-10-01 |
| Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients (NCT00572650) | Novartis | 2007-10-01 |
| BION Treatment of Dysphagia After Radical Head-Neck Surgery (NCT00628485) | University of Southern California | 2007-10-01 |
| Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers (NCT00527150) | Pfizer | 2007-10-01 |
| Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors (NCT01148628) | Southern Europe New Drug Organization | 2007-10-01 |
| Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors (NCT00551096) | University of Colorado, Denver | 2007-10-01 |
| A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects (NCT01520727) | Bial - Portela C S.A. | 2007-10-01 |
| A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED) (NCT00500006) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Assessment of Myocardial Disease in Man Using Novel Non-invasive Diagnostic Tools (NCT00507312) | Prof Henry Krum | 2007-10-01 |
| Safety, Pharmacokinetics and Potential Activity of HE3286 in Obese Adult Subjects (NCT00555451) | Harbor Therapeutics | 2007-10-01 |
| Safety Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke (NCT00756249) | H. Lundbeck A/S | 2007-10-01 |
| Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL (NCT00543114) | Dana-Farber Cancer Institute | 2007-10-01 |
| Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers (NCT02259803) | Boehringer Ingelheim | 2007-10-01 |
| Safety Study of Natalizumab to Treat Multiple Sclerosis (MS) (NCT00559702) | Biogen | 2007-10-01 |
| Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens (NCT00550303) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-10-01 |
| Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide (NCT00629343) | Columbia University | 2007-10-01 |
| Phase 1 Pharmacokinetics of Intravenous Nexium in Children (NCT00474019) | AstraZeneca | 2007-10-01 |
| A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer (NCT00539383) | Angiochem Inc | 2007-10-01 |
| Human Breast Tissue Bioavailability of Topically Applied Limonene (NCT01459172) | University of Arizona | 2007-10-01 |
| Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation (NCT00541788) | University Hospital, Ghent | 2007-10-01 |
| Reducing Health Risk Behavior and Improving Health in Adolescents With Depression (NCT00461539) | University of California, Los Angeles | 2007-10-01 |
| A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population (NCT00534872) | GlaxoSmithKline | 2007-10-01 |
| Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg (NCT00565968) | Duke University | 2007-10-01 |
| Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme (NCT01233492) | Cancer Research UK | 2007-10-01 |
| Continuation Ketamine in Major Depression (NCT00548964) | James Murrough | 2007-10-01 |
| Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese Males (NCT00543946) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-10-01 |
| Safety Study of Multiple Peptide Vaccine to Esophageal Cancer (NCT00561275) | Japanese Foundation for Cancer Research | 2007-10-01 |
| Trial of PBI-05204 in Advanced Cancer Patients (NCT00554268) | M.D. Anderson Cancer Center | 2007-10-01 |
| Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years (NCT00599443) | Solvay Pharmaceuticals | 2007-10-01 |
| Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers (NCT00971295) | Bial - Portela C S.A. | 2007-10-01 |
| A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma (NCT00539344) | Angiochem Inc | 2007-10-01 |
| Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma (NCT00549185) | Sanofi | 2007-10-01 |
| Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine (NCT00560963) | Novartis Pharmaceuticals | 2007-10-01 |
| Single Dose Escalating Study of DAS181 in Adults (NCT00527865) | Ansun Biopharma, Inc. | 2007-10-01 |
| Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) (NCT00542971) | M.D. Anderson Cancer Center | 2007-10-01 |
| Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation (NCT00545259) | Novartis | 2007-10-01 |
| Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma (NCT00545545) | HiberCell, Inc. | 2007-10-01 |
| A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients (NCT00551850) | AVEO Pharmaceuticals, Inc. | 2007-10-01 |
| Memory and Insulin in Early Alzheimer's Disease (NCT00581867) | Jeff Burns, MD | 2007-10-01 |
| PET Study Examining the Dopaminergic Activity of Armodafinil in Adults (NCT00592943) | Massachusetts General Hospital | 2007-10-01 |
| Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 (NCT00753207) | Cancer Trials Ireland | 2007-10-01 |
| Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer (NCT00593008) | Massachusetts General Hospital | 2007-10-01 |
| Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction (NCT00547365) | University of Tennessee | 2007-10-01 |
| A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors (NCT00390936) | Bristol-Myers Squibb | 2007-10-01 |
| A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function (NCT00596518) | Pfizer | 2007-10-01 |
| Use of NAVA in Intubated Preterm (NCT00536445) | Sunnybrook Health Sciences Centre | 2007-10-01 |
| Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients. (NCT00568503) | Novartis | 2007-10-01 |
| Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test) (NCT00845663) | UCB Pharma | 2007-10-01 |
| A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin (NCT00420186) | Bristol-Myers Squibb | 2007-10-01 |
| Native Kidney Denervation in Patients With End Stage Renal Disease (NCT00551304) | Medtronic Vascular | 2007-10-01 |
| Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets (NCT00596245) | GlaxoSmithKline | 2007-10-01 |
| Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers (NCT02214953) | Boehringer Ingelheim | 2007-10-01 |
| Staccato Loxapine Multidose PK (NCT00555412) | Alexza Pharmaceuticals, Inc. | 2007-10-01 |
| Effects of Heme Arginate in Healthy Male Subjects (NCT00682370) | Daniel Doberer | 2007-10-01 |
| Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders (NCT00579137) | Baylor College of Medicine | 2007-10-01 |
| R4Power: An Online Resilience Program for Adolescents (NCT00641368) | Swarthmore College | 2007-10-01 |
| Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer (NCT00625651) | Amgen | 2007-10-01 |